Targets › SORT1
1 program from 1 company in 1 trial: 1 Phase 1; Oncology.
Functions as a sorting receptor in the Golgi compartment and as a clearance receptor on the cell surface. Required for protein transport from the Golgi apparatus to the lysosomes by a pathway that is independent of the mannose-6-phosphate receptor (M6PR). (UniProt, Q99523)
Open in Phaseline: the race on SORT1, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Theratechnologies | TH1902 SORT1-targeted peptide-drug conjugate | SORT1 | Phase 1 | Solid Tumor | – |
Solid Tumor (1)
protein or peptide (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.